UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 286

Sortiert nach

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Allergy, 2014-05, Vol.69 (5), p.602-616

2014

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

Allergy, 2012-02, Vol.67 (2), p.147-157

2012

Link zum Volltext

Verfügbarkeit prüfen

New topics in bradykinin research

Allergy (Copenhagen), 2011-11, Vol.66 (11), p.1397-1406

2011

Link zum Volltext

Verfügbarkeit prüfen

Novelties in the Diagnosis and Treatment of Angioedema

Journal of investigational allergology & clinical immunology, 2016-01, Vol.26 (4), p.212-221

2016

Link zum Volltext

Verfügbarkeit prüfen

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency

Clinical and experimental allergy, 2014-12, Vol.44 (12), p.1503-1514

2014

Link zum Volltext

Verfügbarkeit prüfen

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course

Clinical and experimental immunology, 2020-09, Vol.201 (3), p.258-265

2020

Link zum Volltext

Verfügbarkeit prüfen

Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients

Journal of internal medicine, 2015-05, Vol.277 (5), p.585-593

2015

Link zum Volltext

Verfügbarkeit prüfen

Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients

Allergy (Copenhagen), 2011-02, Vol.66 (2), p.192-196

2011

Link zum Volltext

Verfügbarkeit prüfen

The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD

Communications biology, 2024-03, Vol.7 (1), p.376-376, Article 376

2024

Link zum Volltext

Verfügbarkeit prüfen

Elevated plasma levels of vascular permeability factors in C1 inhibitor‐deficient hereditary angioedema

Allergy (Copenhagen), 2016-07, Vol.71 (7), p.989-996

2016

Link zum Volltext

Verfügbarkeit prüfen

Alterations of coagulation and fibrinolysis in patients with angioedema due to C1‐inhibitor deficiency

Clinical and experimental immunology, 2012-03, Vol.167 (3), p.472-478

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Allergy (Copenhagen), 2015-10, Vol.70 (10), p.1319-1328

2015

Link zum Volltext

Verfügbarkeit prüfen

Target levels of functional C1-inhibitor in hereditary angioedema

Allergy (Copenhagen), 2012-01, Vol.67 (1), p.123-130

2012

Link zum Volltext

Verfügbarkeit prüfen

The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema

Current molecular medicine, 2010-06, Vol.10 (4), p.354

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study

Clinical and experimental allergy, 2012-06, Vol.42 (6), p.929-935

2012

Link zum Volltext

Verfügbarkeit prüfen

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study

Allergy (Copenhagen), 2012-08, Vol.67 (8), p.1074-1077

2012

Link zum Volltext

Verfügbarkeit prüfen

Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy

Human molecular genetics, 2015-01, Vol.24 (1), p.64-75

2015

Link zum Volltext

Verfügbarkeit prüfen

O002 A randomized trial of subcutaneous C1-inhibitor for the prevention of hereditary angioedema attacks

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S1-S1

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency

Allergy, 2009-02, Vol.64 (2), p.254-257

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency

Allergy (Copenhagen), 2015-12, Vol.70 (12), p.1553-1558

2015

Link zum Volltext

Verfügbarkeit prüfen

C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress

iScience, 2023-09, Vol.26 (9), p.107505-107505, Article 107505

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE

Pediatric allergy and immunology, 2015-05, Vol.26 (3), p.296-297

2015

Link zum Volltext

Verfügbarkeit prüfen

Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration

International archives of allergy and immunology, 2013-01, Vol.161 (1), p.3-9

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacocinétique et pharmacodynamique du lanadelumab chez les patients atteints d’AOH dans l’étude de phase 3 HELP

La revue de medecine interne, 2018-12, Vol.39, p.A186-A187

2018

Link zum Volltext

Verfügbarkeit prüfen

Complement and contact system activation in acute congestive heart failure patients

Clinical and experimental immunology, 2017-11, Vol.190 (2), p.251-257

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(242)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(171)
Science & Technology
(160)
Life Sciences & Biomedicine
(151)
Female
(97)
Male
(87)
Middle Aged
(79)
Immunology
(77)
Adult
(71)
Biological And Medical Sciences
(62)
Allergy
(58)
Medical Sciences
(58)
Angioedema
(55)
Aged
(54)
Angioedema - Genetics
(44)
Adolescent
(38)
Allergy And Immunology
(35)
Hereditary Angioedema
(35)
Complement C1 Inactivator Proteins - Deficiency
(33)
Immunopathology
(31)
Angioedema - Drug Therapy
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

New topics in bradykinin research

Novelties in the Diagnosis and Treatment of Angioedema

High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course

Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients

Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients

The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD

Elevated plasma levels of vascular permeability factors in C1 inhibitor‐deficient hereditary angioedema

Alterations of coagulation and fibrinolysis in patients with angioedema due to C1‐inhibitor deficiency

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Target levels of functional C1-inhibitor in hereditary angioedema

The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study

Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy

O002 A randomized trial of subcutaneous C1-inhibitor for the prevention of hereditary angioedema attacks

Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency

Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency

C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress

Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE

Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration

Pharmacocinétique et pharmacodynamique du lanadelumab chez les patients atteints d’AOH dans l’étude de phase 3 HELP

Complement and contact system activation in acute congestive heart failure patients

Suchergebnisse filtern